Alpha Tau Medical (DRTS) Other Non-Current Liabilities (2020 - 2025)
Alpha Tau Medical's (DRTS) quarterly Other Non-Current Liabilities came in at $5.4 million in Q4 2025, up 60.4% year-on-year from $3.3 million in Q4 2024, and up 60.4% quarter-over-quarter from $3.3 million in Q4 2024.
Alpha Tau Medical (DRTS) Other Non-Current Liabilities (2020 - 2025) Analysis & Trends
Alpha Tau Medical has disclosed Other Non-Current Liabilities across 6 years of filings, most recently posting $5.4 million for Q4 2025.
- Other Non-Current Liabilities for Q4 2025 came in at $5.4 million, up 60.4% year-over-year; the trailing twelve-month figure through Dec 2025 was $5.4 million (up 60.4% YoY), and the FY2025 annual result was $5.4 million, up 60.4% from the prior year.
- Other Non-Current Liabilities came in at $5.4 million for Q4 2025 at Alpha Tau Medical, up from $3.3 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $18.6 million in Q4 2021 to a low of $977000.0 in Q4 2023.
- The 5-year median for Other Non-Current Liabilities is $3.3 million (2024), against an average of $6.1 million.
- Across the five-year window, Other Non-Current Liabilities soared 247.06% in 2021 and slumped 88.04% in 2022, its largest moves.
- Alpha Tau Medical's Other Non-Current Liabilities stood at $18.6 million in 2021, then plunged by 88.04% to $2.2 million in 2022, then plunged by 56.15% to $977000.0 in 2023, then soared by 241.66% to $3.3 million in 2024, then soared by 60.4% to $5.4 million in 2025.
- The last three Other Non-Current Liabilities figures came in at $5.4 million (Q4 2025), $3.3 million (Q4 2024), and $977000.0 (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Alpha Tau Medical | 2,384.20 | -76.42 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.35 Mn |
| Dec 31, 2024 | 3.34 Mn |
| Dec 31, 2023 | 977,000.00 |
| Dec 31, 2022 | 2.23 Mn |
| Dec 31, 2021 | 18.62 Mn |
| Dec 31, 2020 | 5.37 Mn |